Translation Advisory Committee for Diabetes Prevention and Control Programs: Meeting

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following committee meeting.

Name: Translation Advisory Committee for Diabetes Prevention and Control Programs.

Times and Dates: 9 a.m.-6 p.m., March 15, 2000, 9 a.m.-1 p.m., March 16, 2000.

Place: Atlanta Marriott Century, 2000 Century Boulevard, NE, Atlanta, Georgia 30345-3377, phone: 404/325-0000.

Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 50 people.

Purpose: This committee is charged with advising the Director, CDC, regarding policy issues and broad strategies for diabetes translation activities and control programs designed to reduce risk factors, health services utilization, costs, morbidity, and mortality associated with diabetes and its complications. The Committee identifies research advances and technologies ready for translation into widespread community practice; recommends broad public health strategies to be implemented through public health interventions; identifies opportunities for surveillance and epidemiologic assessment of diabetes and related complications; and for the purpose of assuring the most effective use and organization of resources, maintains liaison and coordination of programs within the Federal, voluntary, and private sectors involved in the provision of services to people with diabetes.

Matters to Be Discussed: The Diabetes and Women's Health

Monograph. This is a publication which will take an analytical and public health perspective on diabetes among women in the United States. Through separate chapters devoted to specific stages of the life cycle of the woman(adolescence, childbearing age, middle age, and older age) the following topics will be covered: demographic information; epidemiologic analysis; the influence of psycho-social, cultural, behavioral, and socioeconomic factors on susceptibility to the disease or its many complications; cost concerns for patients and the public; assessment of gaps for patient, family, health care provider, and community in knowledge and care; and a discussion of public health considerations. A final chapter will consolidate the findings with recommendations for directing appropriate research and for developing effective programs and interventions. This meeting will focus on the reproductive and elderly years of women. A draft agenda is attached.

Agenda items are subject to change as priorities dictate.

Contact Person for More Information: Norma Loner, Committee Management Specialist, Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, CDC, 4770 Buford Highway, NE, M/S K-10, Atlanta, Georgia 30341-3717, telephone 770/488-5376.

The Director, Management Analysis and Services office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.